Literature DB >> 2196264

c-myc overexpression is a tumor-specific phenomenon in a subset of human colorectal carcinomas.

A Viel1, R Maestro, G Toffoli, G Grion, M Boiocchi.   

Abstract

The transcriptional activity of the c-myc proto-oncogene was examined in 25 primary human colorectal carcinomas and their corresponding normal mucosae. The purpose was to determine whether the elevated levels of c-myc expression, frequently detected in this type of tumor, might be the consequence of alterations in the cell growth rate or the effect of a real transcriptional deregulation of the gene. In about 44% of the tumors the elevated c-myc expression was consequent to the enhanced growth rate of the neoplastic tissue, as estimated by the expression of the S-phase-specific histone H3 gene. In the other 56%, c-myc overexpression did not entirely depend on the proliferative activity of the neoplastic population. In this latter group, c-myc deregulation did not reside in structural modifications of the putative regulatory regions of the gene. Therefore, c-myc overexpression, at least in a subset of colorectal cancer, seems to be consequent to alterations in transregulative phenomena exerted on the c-myc gene by other genetic loci.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2196264     DOI: 10.1007/bf01612905

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  39 in total

1.  c-myc oncogene alterations in human thyroid carcinomas.

Authors:  L del Senno; R Gambari; E degli Uberti; R Barbieri; F Bernardi; D Buzzoni; G Marchetti; G Pansini; C Perrotta; F Conconi
Journal:  Cancer Detect Prev       Date:  1987

Review 2.  The cell cycle.

Authors:  R Baserga
Journal:  N Engl J Med       Date:  1981-02-19       Impact factor: 91.245

3.  Reduced genomic 5-methylcytosine content in human colonic neoplasia.

Authors:  A P Feinberg; C W Gehrke; K C Kuo; M Ehrlich
Journal:  Cancer Res       Date:  1988-03-01       Impact factor: 12.701

4.  Homogeneously staining chromosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma.

Authors:  K Alitalo; M Schwab; C C Lin; H E Varmus; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

5.  Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation.

Authors:  J Campisi; H E Gray; A B Pardee; M Dean; G E Sonenshein
Journal:  Cell       Date:  1984-02       Impact factor: 41.582

6.  Evidence that the familial adenomatous polyposis gene is involved in a subset of colon cancers with a complementable defect in c-myc regulation.

Authors:  M D Erisman; J K Scott; S M Astrin
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

7.  Expression of c-myc and other cell cycle-dependent genes in human colon neoplasia.

Authors:  B Calabretta; L Kaczmarek; P M Ming; F Au; S C Ming
Journal:  Cancer Res       Date:  1985-12       Impact factor: 12.701

8.  Trans-acting elements modulate expression of the human c-myc gene in Burkitt lymphoma cells.

Authors:  J Chung; E Sinn; R R Reed; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

9.  Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma.

Authors:  P G Pelicci; D M Knowles; I Magrath; R Dalla-Favera
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

10.  Truncation of exon 1 from the c-myc gene results in prolonged c-myc mRNa stability.

Authors:  P H Rabbitts; A Forster; M A Stinson; T H Rabbitts
Journal:  EMBO J       Date:  1985-12-30       Impact factor: 11.598

View more
  6 in total

Review 1.  Epigenetics of colorectal cancer.

Authors:  Ajay Goel; C Richard Boland
Journal:  Gastroenterology       Date:  2012-09-20       Impact factor: 22.682

2.  Correlation between chromosome 5q deletions and different mechanisms of c-myc overexpression in human colorectal cancer.

Authors:  R Maestro; A Viel; M Boiocchi
Journal:  Br J Cancer       Date:  1991-02       Impact factor: 7.640

3.  Pre-Analytical Determination of the Effect of Extended Warm or Cold Ischaemia on RNA Stability in the Human Ileum Mucosa.

Authors:  Serene M L Lee; Celine Schelcher; Reinhard Thasler; Tobias S Schiergens; Wolfgang E Thasler
Journal:  PLoS One       Date:  2015-09-15       Impact factor: 3.240

4.  Linking FOXO3, NCOA3, and TCF7L2 to Ras pathway phenotypes through a genome-wide forward genetic screen in human colorectal cancer cells.

Authors:  Snehangshu Kundu; Muhammad Akhtar Ali; Niklas Handin; Narendra Padhan; Jimmy Larsson; Maria Karoutsou; Kenneth Ban; Jacek R Wiśniewski; Per Artursson; Liqun He; Mats Hellström; Tobias Sjöblom
Journal:  Genome Med       Date:  2018-01-04       Impact factor: 11.117

5.  Loss of heterozygosity at the 5,10-methylenetetrahydrofolate reductase locus in human ovarian carcinomas.

Authors:  A Viel; L Dall'Agnese; F Simone; V Canzonieri; E Capozzi; M C Visentin; R Valle; M Boiocchi
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  Chromosomal localisation of two putative 11p oncosuppressor genes involved in human ovarian tumours.

Authors:  A Viel; F Giannini; L Tumiotto; F Sopracordevole; M C Visentin; M Boiocchi
Journal:  Br J Cancer       Date:  1992-12       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.